コンテンツにスキップ

家 > 寄付活動 > Pediatric Cystic…

Revolutionizing Care for Kids with Cystic Fibrosis

Cystic Fibrosis Center

Children with cystic fibrosis (CF) need regular care for a range of serious health issues that can lead to life-threatening complications. Through innovative research, Stanford is working to solve the most pressing problems facing cystic fibrosis patients and their families to help them lead their fullest lives.

今すぐ寄付する

Addressing the Most Urgent Needs

The Stanford School of Medicine is working on multiple projects to address the urgent needs of the entire cystic fibrosis (CF) community. Lung problems are the most serious complications for kids with CF. Our pediatric team is working to identify the best ways to control infections and detect lung disease earlier to help all patients with CF. We’re also at the forefront of investigating CF treatment in utero.

Stanford’s unique focus on restoring mucus clearance to improve lung function and decrease lung damage has the potential to make a tremendous impact on patients who don’t respond to modulator therapy.

Our goal is to unlock the mysteries of this complex disease and drastically improve treatment options, leading to a better quality of life for all kids with CF. With your help, we can achieve this.

Stanford’s pediatric program is designated as a Therapeutics Development Center by the Cystic Fibrosis Foundation, recognizing us as a research hub for innovation in CF care. We collaborate with Stanford experts across multiple disciplines, including bioengineering, molecular biology, and cutting-edge gene therapy.

Nearly 40,000

Number of kids and adults in the U.S. who have cystic fibrosis

10 million

People in the U.S. who are CF carriers

Cystic Fibrosis Researchers Leading the Way

Carlos Milla, MD, is the director of the Stanford Medicine Children’s Health Cystic Fibrosis Center. Under his leadership, the center has become a hub for research and care, leveraging expertise across Stanford. Dr. Milla’s latest studies focus on improving lung function and controlling infections in CF patients.

続きを読む

Matthew Porteus, MD, PhD, is the Sutardja Chuk Professor and director of Stanford’s Center for Definitive and Curative Medicine, where researchers are working to cure currently incurable diseases. He is a winner of the Cystic Fibrosis Research Institute’s CF Champion Award. Dr. Porteus and his team are conducting pioneering research in stem cell therapy to treat chronic sinusitis from CF.

続きを読む

Ron Kopito, PhD, is a cell biologist with a lifelong interest in cystic fibrosis. In collaboration with the Milla and Porteus labs, Dr. Kopito’s team uses advanced approaches in molecular biology to identify potential drug targets for new therapies for patients with mutations who don’t respond to current treatment.

続きを読む

インパクトの機会

Philanthropy is vital to advancing early diagnosis and treatments and building a brighter future for children with CF. Your gifts can help us:

Propel groundbreaking research.

We are highly focused on identifying and accelerating new therapies for patients. Support will expand our research on mucus clearance, sustain investigations into infection control, and build on cell biology studies to better understand the CF gene.

Train the next generation of cystic fibrosis researchers.

With philanthropic support, we can increase the size of our team, speed up discoveries, and bring more innovative therapies to patients in clinical trials. Gifts will hasten and expand our patient-centered research by helping us attract and retain early-career scientists with expertise in CF.

Enhance patient care through state-of-the-art tech.

Your support will enable us to purchase technologies and equipment to address the evolving needs of our pediatric patients with CF. Using the most sophisticated equipment available, we can elevate how we assess, monitor, and treat patients, further improving their quality of life.

Help fuel our trailblazing work — so every child with cystic fibrosis can live their best life.

Get In Touch